[ET Net News Agency, 17 February 2023] HAOHAI BIOTEC (06826) rose 9.62% to HK$47.3.
It hits an intra-day high of HK$47.7, hitting a 52-week high, and an intra-day low of
HK$42.7. The total shares traded was 586,100, with a value of HK$26.78m. The active
buy/sell ratio is 89:11, with net buying turnover of HK$20.73m. BARCLAYS CAPITAL ASIA
accounts for greatest net responsive buying turnover of HK$922,573, with volume weighted
average price of HK$45.187. HSBC SEC BRO (ASIA) accounts for greatest net responsive
selling turnover of HK$9.03m, with volume weighted average price of HK$45.792.

Basic Information
=================

----------------------------------
Nominal 47.300 % Chg +9.62%
High 47.700 Low 42.700
Shares Tr 586,100 Turnover 26.78m
10-D SMA 42.105 %H.V 57.774
20-D SMA 42.262 VWAP 45.695
50-D SMA 38.290 RSI14 65.209
----------------------------------
Status: Hitting a 52-week high, active buy/sell ratio is 89:11, with net buying turnover
of HK$20.73m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
---------------------------------------------
HAOHAI BIOTEC (06826) 47.30 +9.62
JACOBIO-B (01167) 8.36 +6.09
GENSCRIPT BIO (01548) 22.35 +1.59
INNOVENT BIO (01801) 40.35 -0.12
BRII-B (02137) 6.77 +3.20
WUXI BIO (02269) 56.85 -1.73
AKESO-B (09926) 42.85 +1.06
ALPHAMAB-B (09966) 13.76 Unchanged
INNOCARE-B (09969) 9.06 +2.37
REMEGEN-B (09995) 56.60 +0.80
---------------------------------------------
(ed)